Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
29 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 September and 28 September 2023 Download
22 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 September and 21 September 2023 Download
15 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 8 September and 14 September 2023 Download
08 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 September and 7 September 2023 Download
01 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 25 August and 31 August 2023 Download

Pages

Date Title Description PDF
27 Feb 2014 Informe anual de remuneraciones de consejeros 2013 Download
27 Nov 2013 Acuerdos estratégicos con terceros Download
26 Nov 2013 Acuerdos estratégicos con terceros Download
07 Nov 2013 Información sobre resultados (4) Download
07 Nov 2013 Información sobre resultados (3) Download

Pages